Clinical Practice Documents

This expert consensus document is on managing patients with ischemic cardiomyopathy, including triggers for specialized heart failure care, choice of surgical interventions, and measures to improve outcomes.

Read ECD

The goal of this expert consensus document for the surgical treatment of ATAAD is to improve quality of care in a true surgical emergency. These recommendations should serve surgeons, emergency room physicians, and any health care provider who cares for patients with ATAAD.

Read ECD

This is a companion document to a recently issued document regarding management of EA in neonates and infants. This document addresses children older than 1 year of age and adults.

Read ECD

Symptomatic neonates and infants with Ebstein anomaly (EA) require complex management. Here a group of experts provide a framework on this topic focusing on risk stratification and management.

Read ECD Watch Presentation

The goal of these recommendations is to provide families and their health care teams with a framework for clinical decision making based on the literature and expert opinions.

Read ECD Watch Presentation

This expert consensus document and presentation aims to provide practitioners, especially fellow-level trainees or early career physicians, with a framework on which to base the initial categorization of TOF patients and treatment options.

Read ECD Watch Presentation

Consensus multimodality recommendations that account for lesion- and patient-specific variables are presented to facilitate enhanced recovery after pediatric cardiac surgery.

Read ECD

This document and presentation goals are to review the existing literature and report consensus among a group of multidisciplinary experts, providing specific recommendations for the clinical management of subsolid nodules.

Read ECD Watch Presentation

This document, webinar, and presentation goals are to review novel targeted therapy and immunotherapy drugs that have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

Read ECD Watch Webinar Watch Presentation

Identifying who is at risk is important and in evolution. The objective of this expert panel was to review important considerations and factors in assessing who is at high risk among patients considered for lobectomy.

Read ECD

This document and presentation goals are to offer easily implementable, pragmatic, and uniform recommendations for donor lung procurement and preservation.

Read ECD Watch Presentation

Adult heart transplantation using DCD was restarted in 2014. Since then, there has been increasing use of DCD for heart transplantation; early outcomes are equal to those achieved with DBD donors.

Read ECD Watch Presentation

This document and presentation goals are to systematically review the available literature on the use of MCS and to determine recommended use criteria for MCS in the peritransplantation period.

Read ECD Watch Presentation

Joint Guidelines from The Society of Thoracic Surgeons and American Association for Thoracic Surgery.

Read Guidelines

A significant proportion of patients with stage I non–small cell lung cancer (NSCLC) are considered at high risk for complications or mortality after lobectomy.

Read Paper

An expert panel identified several key lung-nodule-related factors to consider when evaluating treatment options for high-risk patients with stage I NSCLC and ranked them by importance.

Read Paper

Image-guided thermal ablation (IGTA) applied to pulmonary pathology is an alternative to surgery in high-risk patients with stage I non-small cell lung cancer (NSCLC).

Read Paper

Sublobar resection offers a parenchymal-sparing surgical alternative to lobectomy and includes wedge resection and segmentectomy.

Read Paper

Stereotactic ablative radiotherapy (SABR) has emerged as an alternative, non-surgical treatment for high-risk patients with stage I non-small cell lung cancer (NSCLC) with increased use over time.

Read Paper

The Clinical Practice Standards Committee of the American Association for Thoracic Surgery assembled an expert panel and conducted a systematic review of the literature detailing studies directly comparing treatment options for high-risk patients with stage I non-small cell lung cancer (NSCLC).

Read Paper